# Effect of Chemotherapy on TMB in NSCLC

> **NCT03683407** · — · UNKNOWN · sponsor: **Baodong Qin** · enrollment: 30 (estimated)

## Conditions studied

- Chemotherapy Effect
- Immunotherapy
- Tumor Mutation Burden
- PD-1/L1 Inhibitor

## Interventions

- **OTHER:** Next-Genernation Sequence

## Key facts

- **NCT ID:** NCT03683407
- **Lead sponsor:** Baodong Qin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683407, "Effect of Chemotherapy on TMB in NSCLC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03683407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*